Market Currents
More on Array BioPharma (ARRY): FQ4 beats on a 9% Y/Y jump in total revenue. Net losses were...
-
Monday, August 13, 2012, 4:46 PM ETMore on Array BioPharma (ARRY): FQ4 beats on a 9% Y/Y jump in total revenue. Net losses were pared significantly from the prior year period, as its top line was boosted by a jump in sales and its bottom line benefited from milestone payments from AMGN. Shares +6.6% AH.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
